GLP-1s explained: what to actually expect month by month
A calm, evidence-based walkthrough of what happens when you start semaglutide or tirzepatide — appetite, energy, side effects, and progress.
GLP-1 receptor agonists are the most-studied appetite-regulating medications in modern medicine. They work by mimicking a hormone your gut naturally releases after meals, slowing gastric emptying and quieting the food-noise most patients describe as constant.
Month 1
The first four weeks are almost always a titration phase. Doses start low deliberately — this is what keeps GI side effects manageable. Expect subtle appetite changes, occasional nausea after large or fatty meals, and modest early weight loss driven mostly by reduced intake.
Months 2–3
As the dose climbs, most patients notice the shift they came for: earlier fullness, less snacking, quieter cravings. Weight loss typically accelerates here, averaging one to two pounds per week when paired with adequate protein and resistance training.
Months 4–6
Progress becomes a rhythm rather than a race. Your provider may hold the dose, step up, or step down based on tolerance and results. Muscle preservation, hydration, and sleep matter more than any additional dose increase.
The honest caveats
GLP-1s are a tool, not a cure. Stopping them without lifestyle scaffolding usually leads to regain. Side effects — nausea, constipation, fatigue — are dose-dependent and almost always manageable with pacing and hydration.
Start a physician-guided visit
A licensed U.S. provider reviews every intake — usually within a business day.
Explore treatments